{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:18:28Z","timestamp":1791418708316,"version":"4.3.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/toxsci\/kfu268","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T01:55:15Z","timestamp":1418349315000},"page":"163-172","source":"Crossref","is-referenced-by-count":81,"title":["Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase"],"prefix":"10.1093","volume":"144","author":[{"given":"Tanja S.","family":"Zabka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca M.","family":"Liederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Oeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara A.","family":"Kauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghi","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Farman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirdesh","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Dragovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah L.","family":"Misner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"key\n\t\t\t\t20170315192202_kfu268-B1"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2174\/092986711795590101","article-title":"NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism","volume":"18","author":"Burgos","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B3","doi-asserted-by":"crossref","first-page":"22408","DOI":"10.1074\/jbc.M112.357301","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nictonic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner","volume":"287","author":"Cerna","year":"2012","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B28","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyana","year":"2013","journal-title":"PNAS."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2361","article-title":"NMNAT1 mutations cause Leber congenital amaurosis","volume":"44","author":"Falk","year":"2012","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B5","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoryltransferase, represents a novel mechanism for induction of tumor cell apoptosis","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10637-007-9083-2","article-title":"The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor","volume":"26","author":"Holen","year":"2008","journal-title":"Investigational New Drugs"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B7","first-page":"2843","article-title":"A Phase I study of CHS 828 in patients with solid tumor malignancy","volume":"8","author":"Hovstadius","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.ne.02.030179.001125","article-title":"Physiology of the retina","volume":"2","author":"Kaneko","year":"1979","journal-title":"Ann. Rev. Neurosci."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B9"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B10","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1593\/neo.131718","article-title":"Supplementation of nicotonic acid with NAMPT inhibitors results in loss of in\u00a0vivo efficacy in NAPRT1-deficient tumor models","volume":"15","author":"O\u2019Brien","year":"2013","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/cbic.201402023","article-title":"Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase","volume":"15","author":"Oh","year":"2014","journal-title":"ChemBioChem"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B12","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1158\/1535-7163.MCT-09-1130","article-title":"A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor","volume":"9","author":"Olesen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ng.2357","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy","volume":"44","author":"Perrault","year":"2012","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B14","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.1303302110","article-title":"Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment","volume":"110","author":"Phan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B15","doi-asserted-by":"crossref","first-page":"A3581","DOI":"10.1200\/jco.2009.27.15_suppl.3581","article-title":"A phase I trial of GMX1777, an inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT), given as a 24-hour infusion","volume":"27","author":"Pishvaian","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ejca.2004.12.023","article-title":"Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG\/EORTC study","volume":"41","author":"Ravaud","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0896-1549(02)00051-2","article-title":"Medications and retinal toxicity","volume":"15","author":"Schwartz","year":"2002","journal-title":"Ophthalmol. Clin. N. Am."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B18","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1158\/1078-0432.CCR-13-1186","article-title":"Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors","volume":"19","author":"Shames","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B29","article-title":"Qualification of the Megakaryocyte Colony Forming Cell assay as an in vitro Model of Nicotinamide Phosphoribosyltransferase Inhibitor-mediated Clinical Thrombocytopenia and Mitigation by Co-Treatment with Nicotinic Acid","author":"Tarrant","year":"2014"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00280-009-1125-3","article-title":"Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data","volume":"65","author":"von Heideman","year":"2010","journal-title":"Cancer Chemo. Pharm."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B21","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1128\/MCB.00112-09","article-title":"The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors","volume":"29","author":"Watson","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1593\/neo.131304","article-title":"Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618","volume":"15","author":"Xiao","year":"2013","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20170315192202_kfu268-B23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ars.2007.1672","article-title":"NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences","volume":"10","author":"Ying","year":"2008","journal-title":"Antioxid. Redox. Signal."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4172\/1948-593X.1000038","article-title":"Nicotinamide phosphoribosylatransferase in human diseases","volume":"3","author":"Zhang","year":"2011","journal-title":"J. Bioanal. Biomed."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B25","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/jm4008664","article-title":"Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors","volume":"56","author":"Zheng","year":"2013","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B26","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.bmcl.2013.08.074","article-title":"Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)","volume":"2","author":"Zheng","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"key\n\t\t\t\t20170315192202_kfu268-B27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1535-7163.TARG-11-C212","article-title":"A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats","volume":"10","author":"Zhou","year":"2011","journal-title":"Mol. Cancer Ther."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/144\/1\/163\/10914873\/kfu268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T21:11:39Z","timestamp":1598562699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kfu268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,11]]},"published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfu268","relation":{},"ISSN":["1096-0929","1096-6080"],"issn-type":[{"value":"1096-0929","type":"electronic"},{"value":"1096-6080","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,11]]}}}